MediPharm Labs Balance Sheet Health
Financial Health criteria checks 6/6
MediPharm Labs has a total shareholder equity of CA$45.0M and total debt of CA$571.0K, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are CA$55.8M and CA$10.8M respectively.
Key information
1.3%
Debt to equity ratio
CA$571.00k
Debt
| Interest coverage ratio | n/a |
| Cash | CA$13.43m |
| Equity | CA$45.05m |
| Total liabilities | CA$10.80m |
| Total assets | CA$55.84m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MLZ's short term assets (CA$34.6M) exceed its short term liabilities (CA$10.8M).
Long Term Liabilities: MLZ's short term assets (CA$34.6M) exceed its long term liabilities (CA$35.0K).
Debt to Equity History and Analysis
Debt Level: MLZ has more cash than its total debt.
Reducing Debt: MLZ's debt to equity ratio has reduced from 4.7% to 1.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MLZ has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: MLZ has sufficient cash runway for 2.4 years if free cash flow continues to grow at historical rates of 25.2% each year.